My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 139

    1.

    Screening for genetic risk of breast cancer.

    Rosenthal TC, Puck SM.

    Am Fam Physician. 1999 Jan 1;59(1):99-104, 106. Review.PMID: 9917577 [PubMed - indexed for MEDLINE]Related articles

    2.

    Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group.

    Vasen HF, Haites NE, Evans DG, Steel CM, Møller P, Hodgson S, Eccles D, Morrison P, Stoppa Lyonet D, Chang-Claude J, Caligo M.

    Eur J Cancer. 1998 Nov;34(12):1922-6.PMID: 10023316 [PubMed - indexed for MEDLINE]Related articles

    3.

    Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.

    Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A.

    J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23.PMID: 11504767 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.

    Botkin JR, Smith KR, Croyle RT, Baty BJ, Wylie JE, Dutson D, Chan A, Hamann HA, Lerman C, McDonald J, Venne V, Ward JH, Lyon E.

    Am J Med Genet A. 2003 Apr 30;118A(3):201-9.PMID: 12673648 [PubMed - indexed for MEDLINE]Related articles

    5.

    Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

    Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB.

    J Natl Cancer Inst. 2001 Nov 7;93(21):1633-7.PMID: 11698567 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.

    Piver MS.

    Oncologist. 1996;1(5):326-330.PMID: 10388011 [PubMed - as supplied by publisher]Related articlesFree article

    7.

    Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

    Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR.

    J Natl Cancer Inst. 1999 Jun 2;91(11):943-9.PMID: 10359546 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.

    Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S.

    J Natl Cancer Inst. 1999 Jul 21;91(14):1241-7.PMID: 10413426 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.

    Calderon-Margalit R, Paltiel O.

    Int J Cancer. 2004 Nov 10;112(3):357-64. Review.PMID: 15382059 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

    Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.

    Gynecol Oncol. 2005 May;97(2):457-67.PMID: 15863145 [PubMed - indexed for MEDLINE]Related articles

    11.

    The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

    Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB.

    Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):467-73.PMID: 11352856 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.

    Anderson K, Jacobson JS, Heitjan DF, Zivin JG, Hershman D, Neugut AI, Grann VR.

    Ann Intern Med. 2006 Mar 21;144(6):397-406.PMID: 16549852 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

    Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.

    Cancer. 2006 Dec 15;107(12):2745-51.PMID: 17109443 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.

    Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ.

    Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):741-7.PMID: 10498392 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers.

    Heisey RE, Carroll JC, Warner E, McCready DR, Goel V.

    Can Fam Physician. 1999 Jan;45:114-24. Review.PMID: 10889864 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

    Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL.

    J Natl Cancer Inst. 1999 Sep 1;91(17):1475-9.PMID: 10469748 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

    Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.

    Clin Cancer Res. 2002 Dec;8(12):3776-81.PMID: 12473589 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Familial breast and ovarian cancers.

    Arai M, Utsunomiya J, Miki Y.

    Int J Clin Oncol. 2004 Aug;9(4):270-82. Review.PMID: 15375703 [PubMed - indexed for MEDLINE]Related articles

    19.

    Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers.

    Eeles RA.

    Breast Cancer Res. 2000;2(4):283-90. Epub 2000 May 25. Review.PMID: 11250722 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The problems with risk selection; scientific and psychosocial aspects.

    Hartman AR.

    Recent Results Cancer Res. 2005;166:125-44. Review.PMID: 15648188 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity